Τόμος 17 (2003) – Τεύχος 3 – Άρθρο 2 – Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Διεθνής Έκδοση – Volume 17 (2003) – Issue 3 – Article 2 – Epitheorese Klinikes Farmakologias και Farmakokinetikes-International Edition

1.       Department of Health Visiting, Faculty of Health and Caring Professions, Technological Educational Institution, Athens, Greece

2.      Department of Surgery, Medical School, Aristotle University, 3rd Surgery Department of Axepa General Hospital, Thessaloniki, Greece

3.      General Department of Essential Medical Subjects, Faculty of Health and Caring Professions, Technological Educational Institution, Athens, Greece

4.      Department of Midwifery, Faculty of Health and Caring Professions, Technological Educational Institution, Athens, Greece

pharmakonpress[at]pharmakonpress[.]gr

Received for publication: 1 September 2003

 Accepted for publication: 20 September 2003

2.    Nagataki S.: The concept of Hashimoto disease. In: Eight years of Hashimoto disease (Nagataki S., Mori T., Torizaka K., eds), pp. 539-545, Elsevier Science, Amsterdam, (1993)

3.    Allahabadia A., Cough S.C.: The different approaches to the genetic analysis of autoimmune thyroid disease. J. Endocrinol 163: 7-13 (1999)

4.    Vanterpump M.P., Tunbridge W.M.: Epidemiology and prevention of clinical and subclinical hypothyroidism. Thyroid 12: 839-847 (2002)

5.    Tomer Y.: Genetic dissection of familial autoimmune thyroid diseases using whole genome screening. Autoimmun. Rev. 1: 198-204 (2002)

6.    Barbesino G., Chiovato L.: The genetics of Hashimoto’s disease. Endocrinol. Metab. Clin. North Am. 29: 357-374 (2000)

7.    Saravanan P., Dayan C. M.: Thyroid autoantibodies. Endocrinol. Metab. Clin. North Am. 30: 315-337 (2001)

8.    Devendra D., Eisenbarth G.S.: Immunologic endocrine disorders. J. Allergy Clin. Immunol. 11 (2 Suppl): S 624-636 (2003)

9.    Jenkins R.C., Weetman A.P.: Disease associations with autoimmune disease. Thyroid 12: 977-988 (2002)

10.  Eguchi K.: Apoptosis in autoimmune diseases. Inter. Med. 40: 275-284 (2001)

11.  Tsatsoulis A.: The role of apoptosis in thyroid disease. Minerva Med 93: 169-180 (2002)

12.  Salmaso C., Bagnasco M., Pesce G., Montagna P., Brizzolara R., Altrinetti V., et al.: Regulation of apoptosis in endocrine autoimmunity: insights from Hashimoto’s thyroiditis and Grave’s disease. Ann. N. Y. Acad. Sci. 996: 496- 501 (2002)

13.  Phelps E., Wu P., Bretz J., Baker J.R., Jr.: Thyroid apoptosis. A new understanding of thyroid autoimmunity. Endocrinol. Metab. Clin. North Am. 29: 375-388, viii (2000)

14.  Marazuela M.: Lymphocyte traffic and homing in autoimmune thyroid disorders. Eur. J. Endocrinol. 140: 287-290 (1999)

15.  Marino M., Latrofa F., Barbesino G., Chiovato L.: Pathogenetic and clinical aspects of autoimmune thyroiditis. Exp. Clin. Endocrinol. Diabetes 107 Suppl 3: S 79-83 (1999)

16.  Mirakian R., Nye K., Palazza F.F., Goode A.W., Hammond L.J.: Methods for detecting apoptosis in thyroid diseases. J. Immunol. Methods 265: 161-175 (2002)

17.  Andrikoula M., Tsasouiis A.: The role of Fas-mediated apoptosis in thyroid disease. Eur. J. Endocrinol. 144: 561- 568 (2001)

18.  Stassi G., Zeuner A., Di Liberto D., Todaro M., Ricci- Vitiani L, De Maria R.: Fas-FasL in Hashimoto’s thyroiditis. J. Clin. Immunol. 21: 19-23 (2001)

19.  Borgerson K.L., Bretz J.D., Baker J.R., Jr.: The role of Fas-mediated apoptosis in thyroid autoimmune diseases. Autoimmunity 30: 251-264 (1999)

20.  Giordano G., Stassi R., De Maria M., Todaro P., Richiusa G., Papoff G., et al.: Potential involvement of Fas and its ligand in the pathogenesis of Hashimoto’s thyroiditis. Science 275: 960-963 (1997)

21.  Orgiazzi J.: The spectrum of autoimmune thyroid diseases (AITD). Ann. Med. Interne (Paris) 150: 294-300 (1999)

22.  Stassi G., De Maria R.: Autoimmune thyroid disease: new models of cell death in autoimmunity. Nat. Rev. Immunol. 2: 195-204 (2002)

23.  Mitsiades N., Poulaki V., Kotoula V., Mastorakos G., Balafouta S., Koutras D.A., et al.: Fas/Fas ligand up-regulation and BCL-2 down-regulation may be significant in the pathogenesis of Hashimoto’s thyroiditis. J. Clln. Endo. Metab. 83: 2199 (1998)

24.  Kawakami A., Eguchi K., Matsuoka N., Tsuboi M., Kawabe Y., Ishikawa N., et al.: Thyroid-stimulating hormone inhibits Fas antigen-mediated apoptosis of human thyrocytes in vitro. Endocrinology 137: 3163 (1996)

25.  Batteux F., Lores P., Bucchini D., Chiocchia G.: Transgenic expression of Fas ligand on thyroid follicular cells prevents autoimmune thyroiditis. J. Immunol. 164: 1681- 1688 (2000)

26.  Mitsiades N., Poulaki V., Mitsiades C.S., Koutras D.A., Croussos C.P.: Apoptosis induced by FasL and TRAIL/Apo2L in the pathogenesis of thyroid diseases. Trends Endocrinol. Metab. 12: 384-390 (2001 )

27.  Dong Z., Takakuwa T., Takayama H., Luo W.J., Takano T., Amino N., et al.: Fas and Fas ligand gene mutations in Hashimoto’s thyroiditis. Lab. Invest. 82: 1611-1616 (2002)

28.  Takakuwa T., Dong Z., Nakatsuka S., Kojya S., Harabuchi Y., Yang W.I., et al.: Frequent mutations of Fas gene in nasal NK/Tcell lymphoma. Oncogene 21: 4702-4705 (2002)

29.  Krogh Ramsmussen A., Harioft-Nielsen M.L., Feldt-Rasmussen U.: Models to study the pathogenesis of thyroid autoimmunity. Biochimie 81: 511-515 (1999)

30.  Nose F., Iscikawa M., Fujiwara M., Okayasu I.: Up-regulation of cycloxygenase-2 expression in lymphocytic thyroiditis and thyroid tumors: significant correlation with inducible nitric oxide synthase. Am. J. Clin. Pathol. 117: 546-551 (2002)

31.  Choe W., Kim S., Hwang T.S., Lee S.S.: Expression of inducible nitric oxide synthase in thyroid neoplasms: immunohistochemical and molecular analysis. Pathol. Int. 53: 434-439 (2003)

32.  Lauberg P., Pedersen K.M., Hreindarsson A., Sigfusson N., Iversen E., Knudsen P.R.: Iodine intake and the pattern of thyroid disorders. A comparative epidemiologic study of thyroid abnormalities in the elderly in Iceland and in Jutland, Denmark. J. Clin. Endocr. Metab. 83: 765-769 (1998)

33.  Nayata K., Takasu N., Akamine K, Ohshiro C., Komiya l., Murakami K., et al.: Urinary iodine and thyroid antibodies in Okinawa, Yamgata, Hyogo, and Nagano, Japan: The differences in iodine intake do not affect thyroid antibody positivity. Endocr. J. 45: 797-803 (1998)

34.  Saboori A.M., Burek C.L.: Linking iodine with autoimmune thyroiditis. Health Perspect. 107 Suppl. 5: (1999)

35.  Dai Y.D., Rao V.P., Carayanniois G.: Enhanced iodination of thyroglobulin facilitates processing and presentation of a cryptic pathogenic peptide. J. Immunol. 168: 5907- 5911 (2002)

36.  Chin H.S., Chin D.K., Morgenthaler N.G., Vassart G., Costagliola S.: Rarity of anti-Na+/l-symporter (NIS) antibody with iodine uptake inhibiting activity in autoimmune thyroid disease (AITD): J. Clin. Endocrinol. Metab. 85: 3937-3940 (2000)

37.  Seissler J., Wagner S., Schott M., Feldkamp J., Scherbaun W.a., Morgenthaler N.G.: Low frequency of autoantibodies to the human Na+/l-symporter (NIS) in patients with autoimmune thyroid disease. J. Clin. Endocrinol. Metab. 85: 4630-4634 (2000)

38.  Elsheikh M., Wass J.a., Conway G.C.: Autoimmune thyroid syndrome in women with Turner’s syndrome – the association with karyotype. Clin. Endocrinol. (Oxf.) 55: 223- 226 (2001)

39.  Παράβα Μ., Ζησόπουλος Aλ., Γλυνιαδάκη Z., Στοϊκίδου Μ., Ανθούλη-Αναγνωστοπούλου Φρ., Τσελίκα A.: Φλεγμονώδεις παθήσεις του θυρεοειδούς αδένος: Θυρεοειδίτιδες. Επιθ. Κλιν. Φαρμακολ. Φαρμακοκινητικής 21: 77-92 (2003)

40.  Sakiyama R.: Thyroiditis: a clinical review. Am. Fam. Physician 48: 615-621 (1993)

41.  Weetman A.P.: Autoimmune thyroid disease: propagation and progression. Eur. J. Endocrinol. 148: 1-9 (2003)

42.  Intenzo C.M., Capuzzi D.M., Jabbour S., Kim S.M., de Papp A.E.: Scintigraphic features of autoimmuno thyroiditis. Radiographics 21: 957-964 (2001)

43.  Dittmar M., Kahaly G.S.: Polyglandular autoimmune syndromes: immunogenetics and long-term follow-up. J. Clin. Endocrinol. Metab. 88: 2983-2992 (2003)

44.  Cambichler T., Linhart C., Wolter M.: Mid-dermal elastolysis associated with Hashimoto’s thyroiditis. J. Eur. Acad. Dermatol. Venereol. 12: 245-249 (1999)

45.  Leonhardt J.M., Heymann W.R.: Autoimmune thyroid diseases: etiology, pathogenesis and dermatologic manifestations. J. Am. Acad. Dermatol. 48: 641-659 (2003)

46.  Niederwieser G., Buchinger W., Bonelli R.M., Berghold A., Reisecker F., Koltringer P., et al.: Prevalence of autoimmune thyroiditis and non-immune thyroid disease in multiple sclerosis. J. Neurol. 250: 672-675 (2003)

47.  Lahita R.G.: Collagen disease: the enemy within. Int J. Fertil. Womens Med. 43: 229-234 (1998)

48.  Chen H.C., Marsharami U.: Hashimoto’s encephalopathy. South Med J. 93: 504-506 (2000)

49.  Peschen-Rosin R., Schabet M., Dichgans J.: Manifestation of Hashimoto’s encephalopathy years before onset of thyroid disease. Eur. Neurol. 41: 79-84 (1999)

50.  Pozo-Rosich P., Viiloslada P., Canton A., Simo R., Rovita A., Montalban X.: Reversible white matter alteration in encephalopathy associated with autoimmune thyroid disease. J. Neurol. 249: 1063-1065 (2002)

51.  Chong J.Y., Rowland L.P., Utiger R.D.: Hashimoto encephalopathy: syndrome or myth? Arch. Neurol. 60: 164-171 (2003)

52.  Sawka A.M., Fatourechi V., Boeve B.F., Mokri B.: Rarity of encephalopathy associated with autoimmune thyroiditis. A case series from Mayo Clinic from 1950 to 1996. Thyroid 12: 393-398 (2002)

53.  Lawrence W., Jr., Kaplan B.J.: Diagnosis and management of patients with thyroid nodules. J. Surg. Oncol. 80: 157-170 (2002)

54.  Yech H.C., Futterweitt W., Gilbert P.: Micronodulation: Ultrasonographic sign of Hashimoto thyroiditis. J. Ultrasound Med. 15: 813-819 (1996)

55.  Pedersen O.M., Aardal N.P., Larssen T.B., Varhaug J.E., Myking O., Vilkmo H.: The value of ultrasonography in predicting autoimmune thyroid disease. Thyroid 10: 251- 259 (2000)

56.  Slatosky J., Shipton B., Wahba H.: Thyroiditis: differential diagnosis and management. Am. Fam. Physician 61: 1047-1052, 1054 (2000)

57.  Wozniac R., Beckwith L., Ratech H., Surks M.I.: Maltoma of the thyroid in a man with Hashimoto’s thyroiditis. J. Clin. Endocrinol. Metab. 84: 1206-1209 (1999)

58.  Takano T., Miyauchi A., Matsuzuka F., Yoshida H., Kuma K., Amino N.: Diagnosis of thyroid malignant lymphoma by reverse transcription-polymerase chain reaction detecting the monoclonality of immunoglobulin heavy chain messenger ribonucleic acid. J. Clin. Endocr. Metab. 85: 671-675 (2000)

59.  Mussa G.C., Corrias A., Mostert M., Pellegrino D., Silvestro L.: Patients with Hashimoto’s disease treated with L-thyroxine and followed for three years. J. Pediatr. Endocrinol. Metab. 11: 59-62 (1998)

60.  Schumm-Draeger P. M., Padberg S., Heller K.: Prophylactic levothyroxine therapy in patients with Hashimoto’s thyroiditis. Exp. Clin. Endocrinol. Diabetes Suppl. 3: S 84-87 (1999)

61.  Padberg S., Heller K., Usadel K.H., Schumm-Draeger P.M.: One-year prophylactic treatment of euthyroid Hashimoto’s thyroiditis patients with levothyroxine: Is there a benefit ? Thyroid 11: 249-255 (2001)

62.  Duntas L.H., Mantzou E., Koutras D.A.: Effects of a six month treatment with selenomethionine in patients with autoimmune thyroiditis. Eur. J. Endocrinol. 148: 389-393 (2003)

63.  Tamini D.M.: The association between chronic lymphocytic thyroiditis and thyroid tumors. Int. J. Surg. Pathol. 10: 141-146 (2002)

64.  Arif S., Blanes A., Diaz-Cano S.J.: Hashimoto’s thyroiditis shares features with early papillary thyroid carcinoma. Histopathology 41: 357-362 (2002)

65.  Okayasu l., Fujiwara M., Hara Y., Tanaka Y., Roce W.R.: Association of chronic lymphocytic thyroiditis and thyroid papillary carcinoma. A study of surgical cases among Japanese, and white African Americans. Cancer 76: 2312-2318 (1995)

66.  Loh K.C., Greenspan F.S., Dang F., Miller T.R., Yeo P.P.: Influence of lymphocytic thyroiditis on the prognostic outcome of patients with papillary thyroid carcinoma. J. Clin. Endocrinol. Metab. 84: 458-463 (1999)

67.  Cornetta A.J., Russel J.P., Cunnane M., Keane W.M., Rothstein J.L.: Cycloxygenase-2 expression in human thyroid carcinoma and Hashimoto’s thyroiditis. Laryngoscope 112: 238-242 (2002)

68.  Singh B., Shaha A.R., Trivedi H., Carew J.F., Poluri A., Shaha J.P.: Coexistent Hashimoto’s thyroiditis with papillary thyroid carcinoma: impact on presentation, management and outcome. Surgery 126: 1070-1077 (1999)

69.  Nikolof V.E.: RET/PTC rearrangement in thyroid tumors. Endocr. Pathol. 13: 3-16 (2002)

70.  Wirtschafter A., Scmidt R., Rosen D., Kundu N., Santoro M., Fusco A., et. al.: Expression of the RET/PTC fusion gene as a marker for papillary carcinoma in Hashimoto’s thyroiditis. Laryngoscope 107: 95-100 (1997)

71.  Mechler C., Bounacer A., Suarez H., Saint Frison M., Mayois C., Aillet G., et al.: Papillary thyroid carcinoma: 6 cases from 2 families with associated lymphocytic harbouring RET/PTC rearrangements. Br. J. Cancer 85: 1831 – 1837 (2001)

72.  Gogas J., Kouskos E., Tseleni-Balafouta S., Markopoulos C., Revenas K., Cogas J., et al.: Autoimmune thyroid disease in women with breast carcinoma. Eur. J. Surg. Oncol. 27: 626-630 (2001)

pharmakonpress[at]pharmakonpress[.]gr

pharmakonpress[at]pharmakonpress[.]gr